Top Markets
Coin of the day
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Kedudukan dalam Saham #40618
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Harga Saham
$1.06
Disegerakkan terakhir: 2021-06-25
Modal Pasaran
$110.93K
Perubahan (1 hari)
-5.36%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Millendo Therapeutics, Inc. (MLND)

Kategori

Sejarah hasil dividen untuk Millendo Therapeutics, Inc. (MLND)
Hasil dividen (TTM) bagi Millendo Therapeutics, Inc. (simbol saham: MLND) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Millendo Therapeutics, Inc. (MLND) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing